Austria as an Innovation Hub: Experts Discuss the Future of Life Sciences
As part of the latest "Schiefer Talk," leading experts from the Austrian healthcare and real estate industries came together to discuss the future of the life sciences sector. The goal of the discussion was to strengthen Austria's position as a key location for medical innovation and modern healthcare solutions.
Participants included Andreas Köttl, President of VÖPE and ÖGNI, and Barbara Sladek, founder and CEO of the company myBioma, among others. Together, they analyzed how research and technological developments could shape Austria as a healthcare hub in the coming years.
A central topic was the connection between health research and sustainable infrastructure. The experts emphasized that modern laboratories and well-equipped research centers are crucial for attracting international talent and investors to Austria. In this context, digitalization is also playing an increasingly important role in utilizing medical data more efficiently.
The discussion highlighted that Austria already possesses a strong foundation in biotechnology. However, to remain globally competitive, closer cooperation between policymakers, the scientific community, and private companies is necessary. Only in this way can new medical products be brought to market more quickly.
In conclusion, the participants agreed that Austria offers great potential as a business location. Through targeted investments and better networking among stakeholders, the country can further expand its role as a European innovation hub for health technologies.